Skip to main content
The Maple Markets

TSX Venture Exchange (TSXV) · NRX.V · ISIN CA67059R1091

NurExone Biologic Inc.

0.6000 CAD

0.09(13.04%)down

Previous close · Sep 18, 14:43 ET

Data last updated: (21 h ago)· Delayed exchange data

Sign in to add to portfolio

NurExone Biologic Inc. (NRX.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 47.71M CAD. Its ISIN is CA67059R1091. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA67059R1091

Sector

Healthcare

Industry

Biotechnology

Country

CA

Market cap

44.04M CAD

Previous close

0.69 CAD

Day range

0.60 – 0.68

52-week range

0.43 – 1.12

Volume

23K

50-day average

0.54 CAD

200-day average

0.61 CAD

Asset type

Equity

About NurExone Biologic Inc.

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

Company website

Frequently asked

+
What is the NRX.V share price today?
This page shows the latest available NurExone Biologic Inc. (NRX.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is NurExone Biologic Inc. listed?
NurExone Biologic Inc. trades on the TSX Venture Exchange under the symbol NRX.V, ISIN CA67059R1091.
+
How large is NurExone Biologic Inc.?
Its market capitalisation is approximately 47.71M CAD, based on the latest available price and share count from our data provider.

All NurExone Biologic Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy